Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by David Nemazee and James Voss.
David Nemazee
Connection Strength
0.524
James Voss
  1. A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs. J Immunol. 2021 07 01; 207(1):344-351.
    View in: PubMed
    Score: 0.238
  2. Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection. Nat Commun. 2021 05 19; 12(1):2938.
    View in: PubMed
    Score: 0.059
  3. Commercial Serology Assays Predict Neutralization Activity against SARS-CoV-2. Clin Chem. 2021 01 30; 67(2):404-414.
    View in: PubMed
    Score: 0.058
  4. Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody. Science. 2021 02 19; 371(6531):823-829.
    View in: PubMed
    Score: 0.058
  5. Broad neutralization of SARS-related viruses by human monoclonal antibodies. Science. 2020 08 07; 369(6504):731-736.
    View in: PubMed
    Score: 0.055
  6. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science. 2020 08 21; 369(6506):956-963.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.